Generics - Generics

Filter

Current filters:

Generics

Popular Filters

1 to 25 of 1153 results

TWi Pharmaceuticals to use its own subsidiary in USA instead of Teva

24-02-2015

Generic drugmakers Taiwan-based TWi Pharmaceuticals and Israeli company Teva Pharmaceutical Industries…

GenericsLicensingLidodermMegace ESOncologyTeva Pharmaceutcal IndustriesTWi PharmaceuticalsUSA

Opportunities, challenges, strategies and forecasts for generic drugs market; report

Opportunities, challenges, strategies and forecasts for generic drugs market; report

23-02-2015

Already prevalent in the USA, Europe and much of the developing world, generic drugs are now finding…

BiosimilarsEuropeGenericsGlobalMarkets & Marketing

Actavis receives final FDA approval for generic version of Subutex

Actavis receives final FDA approval for generic version of Subutex

22-02-2015

Ireland-headquartered generics major Actavis has received final approval from the US Food and Drug Administration…

Abbreviated New Drug ApplicationGenericsIndiviorNeurologicalRC PharmaceuticalsReckitt BenckiserRegulationSubutexUSA

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Russian government may lift duties on imports of pharmaceutical substances

16-02-2015

The Russian government plans to provide subsidies for the production of pharmaceutical substances for…

GenericsMarkets & MarketingOncologyPoliticsProductionRussia

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis to sell its Pharmatech unit to TPG

13-02-2015

Ireland-headquartered generics major Actavis has reached a definitive agreement with TPG, the global…

ActavisAptalis PharmaGenericsMergers & AcquisitionsPharmatech

Julphar takes step into Bangladesh market with RAK Pharma acquisition

Julphar takes step into Bangladesh market with RAK Pharma acquisition

13-02-2015

Julphar, the largest Emirati pharmaceutical company, has acquired a majority stake in Bangladesh drugmaker…

BangladeshGenericsJulpharMergers & AcquisitionsRAK Pharmaceuticals

Hospira fourth-qtr 2014 earnings beat expectations

Hospira fourth-qtr 2014 earnings beat expectations

12-02-2015

US drugmaker Hospira, a leading provider of injectable drugs and infusion technologies, and a global…

FinancialGenericsHospiraPfizerUnited States

Breckenridge Pharma files ANDA for generic of Sanofi’s Jevtana

12-02-2015

Privately-held US generic drugmaker Breckenridge Pharmaceutical has filed an Abbreviated New Drug Application…

Breckenridge PharmaceuticalsGenericsJevtanaOncologyPatentsRegulationSanofiUSA

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

Mylan confirms it is being sued by Bayer over Nexavar patent challenge

10-02-2015

US generics drugmaker Mylan has confirmed that it has been sued by German pharma major Bayer and partner…

BayerGenericsLegalMylanNexavarOncologyOnyx PharmaceuticalsPatentsPatents & Trade marksRegulationUSA

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

US FDA issues another warning letter over failures at Apotex’ Indian plant

US FDA issues another warning letter over failures at Apotex’ Indian plant

09-02-2015

The US Food and Drug Administration has issued yet another warning letter to Canada-headquartered generics…

ApotexApotex Research Private LimitedGenericsIndiaProductionRegulationUSA

Russian government may consider re-purchase from Abbott

09-02-2015

The Russian government may consider the possibility of the re-purchase of the Russian pharmaceutical…

AbbottGenericsMergers & AcquisitionsPoliticsRussiaVeropharm

India needs to reduce reliance on China for APIs

India needs to reduce reliance on China for APIs

08-02-2015

Stiff competition from China is undermining the Indian bulk drug industry. While imports from China are…

Antibiotics and Infectious diseasesChinaGenericsIndiaNeurologicalPoliticsProduction

Cambrex to invest $45-$50 million in API capacity expansion; posts strong financials

06-02-2015

US drugmaker Cambrex has initiated the second significant expansion of its Charles City, Iowa, facility…

CambrexFinancialGenericsProduction

Orexo files US patent infringement law suit against Actavis for Abstral

Orexo files US patent infringement law suit against Actavis for Abstral

06-02-2015

Sweden-based pharma company Orexo has filed a patent infringement law suit in the US District Court for…

AbstralActavisAnalgesiaGenericsLegalOrexoUSA

UPDATE: Pfizer to acquire Hospira for around $17 billion

UPDATE: Pfizer to acquire Hospira for around $17 billion

05-02-2015

US pharma giant Pfizer has entered into a definitive merger agreement to acquire Hospira, news of which…

BiosimilarsGenericsHospiraMergers & AcquisitionsPfizer

Generics will limit growth in French pharma market, says report

Generics will limit growth in French pharma market, says report

04-02-2015

The French pharmaceutical market is forecast to grow at a tepid compound annual growth rate (CAGR) of…

FranceGenericsMarkets & Marketing

1 to 25 of 1153 results

COMPANY SPOTLIGHT

Menarini

Back to top